Amarin's Vascepa May Face Generic Competition In US Next Year After Patents Ruled Invalid

 
• By Brenda Sandburg
  
Fish oil
Court rules patents on Amarin's fish oil pill Vascepa are invalid

More from Legal & IP

More from Business